Davidson A, Manheimer-Lory A, Aranow C, Peterson R, Hannigan N, Diamond B
Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461.
J Clin Invest. 1990 May;85(5):1401-9. doi: 10.1172/JCI114584.
We report the molecular characterization of 2A4, an IgG, DNA-binding antibody bearing the 3I and F4 idiotypes which are associated with anti-DNA antibodies in serum of patients with systemic lupus erythematosus (SLE). The antibody is produced by an EBV-transformed B cell line derived from a patient with multiple myeloma whose myeloma protein is also an IgG, 3I-reactive, F4-reactive, DNA-binding immunoglobulin, although the 2A4 antibody does not itself represent the myeloma protein. The 2A4 heavy chain is encoded by a VH4 gene, a D-D gene fusion and the JH6 gene; the light chain is derived from a Vk1 gene and the Jk2 gene. This is the first human antibody shown to have a CDR3 encoded by a D-D fusion. DNA sequence analysis of the 2A4 VH gene together with a Southern blot of genomic DNA probed with a 2A4 VH-specific oligonucleotide strongly suggest it to be somatically mutated. The data provide evidence that human autoantibodies can be products of somatically mutated genes and suggest that the 2A4 antibody may reflect the selective pressure of antigen.
我们报告了2A4的分子特征,2A4是一种IgG型DNA结合抗体,带有3I和F4独特型,这些独特型与系统性红斑狼疮(SLE)患者血清中的抗DNA抗体相关。该抗体由一株EBV转化的B细胞系产生,该细胞系来源于一名多发性骨髓瘤患者,其骨髓瘤蛋白也是一种IgG型、3I反应性、F4反应性、DNA结合免疫球蛋白,尽管2A4抗体本身并不代表骨髓瘤蛋白。2A4重链由一个VH4基因、一个D-D基因融合体和JH6基因编码;轻链来源于Vk1基因和Jk2基因。这是首个显示其互补决定区3(CDR3)由D-D融合体编码的人源抗体。对2A4 VH基因的DNA序列分析以及用2A4 VH特异性寡核苷酸探测基因组DNA的Southern印迹分析强烈表明它是体细胞突变的。这些数据提供了证据,证明人自身抗体可能是体细胞突变基因的产物,并表明2A4抗体可能反映了抗原的选择压力。